At ICE Bioscience, we offer advanced services designed to support research in cell signaling and drug discovery. Our assay portfolio provides insights into protein dynamics, including expression levels and post-translational modifications such as phosphorylation and methylation. By combining sensitive detection technologies with quantitative analysis, these services help characterize cellular mechanisms and their implications in disease and therapeutic development.
Western blotting, fluorescent Western blotting, digital Western blotting (Jess), flow cytometry, immunofluorescence assay (IFA), ELISA, HTRF, and AlphaLISA support quantitative analysis of protein levels and post-translational modifications.
Fluorescent and digital Western blotting, HTRF, and AlphaLISA enable simultaneous detection of multiple proteins for deeper analysis of signaling pathways and cellular responses.
Assays are designed to provide reliable and reproducible measurements, including the detection of low-abundance proteins.
Tailored assay development is available for basic research studies and applied drug discovery programs.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Get a quote
Go top